Stress-induced processing body formation in tobacco suspension cells

2012 ◽  
Vol 29 (1) ◽  
pp. 80-84
Author(s):  
Bei-xin MO ◽  
Hao YE ◽  
Zhong-hua OU ◽  
Li LIU ◽  
Biao HUANG ◽  
...  
2002 ◽  
Vol 48 (5) ◽  
pp. 753-757 ◽  
Author(s):  
Eiji Okuma ◽  
Kenji Soeda ◽  
Miho Fukuda ◽  
Mikiro Tada ◽  
Yoshiyuki Murata

2009 ◽  
Vol 9 (1) ◽  
pp. 27 ◽  
Author(s):  
Mari Aidemark ◽  
Carl-Johan Andersson ◽  
Allan G Rasmusson ◽  
Susanne Widell

1980 ◽  
Vol 9 (3) ◽  
pp. 229-230 ◽  
Author(s):  
Takayuki Suga ◽  
Tadashi Aoki ◽  
Toshifumi Hirata ◽  
Ym Sook Lee ◽  
Osamu Nishimura ◽  
...  

1979 ◽  
Vol 63 (1) ◽  
pp. 191-194 ◽  
Author(s):  
Irvin J. Mettler ◽  
Robert T. Leonard

2015 ◽  
Vol 63 (19) ◽  
pp. 4728-4736 ◽  
Author(s):  
Andreas A. Hildebrand ◽  
Beate N. Kohn ◽  
Erika Pfeiffer ◽  
Daniel Wefers ◽  
Manfred Metzler ◽  
...  

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Chang Yin ◽  
Rakesh C Kukreja

mRNA Processing Body (P-Body) is a specialized cytoplasmic structure that functions as a major site for post-transcriptional and trnanslational repression. Target mRNA is guided into P-Body through base-pairing with its micro-RNA (miRNA), where they further bind to P-Body components such as GW182 and AGO2; thus get retained away from translation machinery or degraded. Our previous study detected an increase of a key component of P-Body, miRNA, in heat-shock (HS) protected hearts. To gain further insights into the protective mechanism, we hypothesized that the miRNA-associated protection is mediated through P-Body formation. This hypothesis was tested by measuring three key components of P-Body, i.e., miRNA (target seeker), GW182 (marker of P-Body, also called GW-Body) and AGO2 (mRNA catalytic enzyme). METHODS : ICR mice were either HS-preconditioned (15 min, 42°C, anal temperature) or kept at room temperature (controls). miRNA and proteins were extracted 2 hour after HS. miRNA induction was verified by RT-PCR. P-Body formation was evaluated by measuring the binding of GW182 and AGO2, using a combination of immunopricipitation and Western blotting techniques. To study the role of miRNA in P-Body formation, identical experiments were also repeated in mice treated with miRNA-1 inhibitor (antisense miRNA-1 with 2′-O-methyl base at every nucleotide). RESULTS : Compared to the control, HS-preconditioning significantly induced miRNA-1 (150 ± 11%, mean ± SEM), miRNA-21 (71 ± 10%) and miRNA-24 (68 ± 14%). GW182 (109 ± 16%) and AGO2 (50 ± 16%) were also increased in the HS-group. More importantly, there was an increase (39 ± 11%) in co-immunopricipitation between GW182 and AGO2 in the HS-group than in the control, indicating more binding of the two key P-Body components. However, this co-immunoprecipitation was significantly reduced (−68 ± 8%) in the mice treated with the miRNA-1 inhibitor after HS. CONCLUSION : The formation of P-Body following HS-preconditioning represents a novel protective pathway against ischemic injury. The pharmaceutical potential of P-Body formation may offer a new strategy in cardiac preconditioning.


1999 ◽  
Vol 87 (3) ◽  
pp. 302-306 ◽  
Author(s):  
Delphine Verdelhan Des Molles ◽  
Véronique Gomord ◽  
Maryse Bastin ◽  
Loïc Faye ◽  
Didier Courtois

Planta ◽  
2013 ◽  
Vol 238 (4) ◽  
pp. 727-737 ◽  
Author(s):  
Jiao Jiao ◽  
Benguo Zhou ◽  
Xiaoping Zhu ◽  
Zhengliang Gao ◽  
Yuancun Liang

Sign in / Sign up

Export Citation Format

Share Document